Advertisement
Screener

cbdMD, Inc. (YCBD) Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted

1.4 / 5 stars · 23/81 Roast Me

cbdMD, Inc. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted

cbdMD, Inc. (YCBD) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of -$74.09 million for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-15.

Discontinued › Income Statement › Other Income

us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2022-12-15

  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2022-03-31 was -$5.66M.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2021-12-31 was -$20.16M.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2021-09-30 was -$4.36M.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2021-06-30 was $977.01K.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2022 was -$74.09M.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2021 was -$25.95M, a 311.24% decline from fiscal 2020.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2020 was $12.28M.
  • cbdMD, Inc. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2019 was -$45.43M.
Period endNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 monthNet Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month as first filed
2022-09-30-$74.09M
10-K · filed 2022-12-15
2022-03-31-$5.66M
10-Q · filed 2022-05-13
-$25.82M
10-Q · filed 2022-05-13
-$30.18M
derived: sum of 3 quarters · filed 2022-12-15
-$29.20M
derived: sum of 4 quarters · filed 2022-12-15
2021-12-31-$20.16M
10-Q · filed 2022-02-10
-$24.52M
derived: sum of 2 quarters · filed 2022-12-15
-$23.54M
derived: sum of 3 quarters · filed 2022-12-15
-$36.62M
derived: sum of 4 quarters · filed 2022-12-15
2021-09-30-$4.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-15
-$3.38M
derived: sum of 2 quarters · filed 2022-12-15
-$16.45M
derived: sum of 3 quarters · filed 2022-12-15
-$25.95M
10-K · filed 2022-12-15
2021-06-30$977.01K
10-Q · filed 2021-08-12
-$12.09M
derived: sum of 2 quarters · filed 2022-05-13
-$21.59M
10-Q · filed 2021-08-12
-$27.95M
derived: sum of 4 quarters · filed 2022-05-13
2021-03-31-$13.07M
10-Q · filed 2022-05-13
-$22.57M
10-Q · filed 2022-05-13
-$28.93M
derived: sum of 3 quarters · filed 2022-05-13
-$37.97M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$9.50M
10-Q · filed 2022-02-10
-$15.85M
derived: sum of 2 quarters · filed 2022-02-10
-$24.90M
derived: sum of 3 quarters · filed 2022-02-10
-$10.12M
derived: sum of 4 quarters · filed 2022-02-10
2020-09-30-$6.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-17
-$15.40M
derived: sum of 2 quarters · filed 2021-12-17
-$619.83K
derived: sum of 3 quarters · filed 2021-12-17
$12.28M
10-K · filed 2021-12-17
$12.28M
10-K · filed 2020-12-22
2020-06-30-$9.04M
10-Q · filed 2021-08-12
$5.74M
derived: sum of 2 quarters · filed 2021-08-12
$18.64M
10-Q · filed 2021-08-12
$32.99M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$14.78M
10-Q · filed 2021-05-12
$27.69M
10-Q · filed 2021-05-12
$42.04M
derived: sum of 3 quarters · filed 2021-05-12
$15.10M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$12.90M
10-Q · filed 2021-02-09
$27.25M
derived: sum of 2 quarters · filed 2021-02-09
$320.25K
derived: sum of 3 quarters · filed 2021-02-09
$320.25K
derived: sum of 4 quarters · filed 2021-02-09
2019-09-30$14.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-22
-$12.58M
derived: sum of 2 quarters · filed 2020-12-22
-$12.58M
derived: sum of 3 quarters · filed 2020-12-22
-$45.43M
10-K · filed 2020-12-22
2019-06-30-$26.93M
10-Q · filed 2020-08-12
-$26.93M
derived: sum of 2 quarters · filed 2020-08-12
-$59.78M
10-Q · filed 2020-08-12
2019-03-31$0.00
10-Q · filed 2020-05-15
$0.00
10-Q · filed 2020-05-15
2018-12-31$0.00
10-Q · filed 2020-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BONK, INC. (BNKK)United States$0.011B-0.14
Caring Brands, Inc. (CABR)United States$0.013B
UNITED GUARDIAN INC (UG)United States$0.034B13.30
Axil Brands, Inc. (AXIL)United States$0.042B17.24
SOLESENCE, INC. (SLSN)United States$0.058B-25.13
EDGEWELL PERSONAL CARE Co (EPC)United States$1.261B-13.27
COTY INC. (COTY)United States$2.307B-3.15
INTERPARFUMS INC (IPAR)United States$3.707B21.36
e.l.f. Beauty, Inc. (ELF)United States$5.934B
Kenvue Inc. (KVUE)United States$33.844B22.14